Bluestem Biosciences

Omaha, NE · Founded 2022 · Privately Held (backing)

Developer of a digital biology platform designed to build biology for strategic opportunities around agriculture and infrastructure. Bluestem Biosciences is based in Omaha, NE and was founded in 2022. It was valued at $135 million at its seed round in Dec 2025, the last priced event on record. It has raised $21 million across 1 recorded round; the latest was a $5 million early-stage round in Jul 2022.

PMV mark · valuation
$135.0M
Oct 2026
Priced at
its seed round
Dec 2025
Total raised
$21.0M
Last round
Early Stage VC
Jul 2022
How much has Bluestem Biosciences raised?
$21.0Macross 1 recorded rounds · Jul 2022 – Jul 2022

Most recently, Bluestem Biosciences raised $5.0M in its Early Stage VC (Jul 2022).

Free account
More of Bluestem Biosciences with a free account
  • ·Watch Bluestem Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Bluestem Biosciences round by round

1 rounds
Jul 2022Early Stage VC$5.0MSEC filing▮
19 investors participated

How much has Bluestem Biosciences raised?

Bluestem Biosciences has raised $21 million in total; 1 of its rounds is on record. The largest on record was a $5 million early-stage round in Jul 2022.

Bluestem Biosciences has filed 1 Form D with the SEC, most recently in Aug 2022 ($5 million sold to 19 investors).

Bluestem Biosciences investors

9 investors are on record for Bluestem Biosciences, including US National Science Foundation, U.S. Department of Energy, Invest Nebraska and Zero Infinity Partners. The early-stage round in Jul 2022 drew 19 investors.

For fundraisers
Raising for a company like Bluestem Biosciences?

9 investors have backed Bluestem Biosciences.

See all 9 investors →

Frequently asked about Bluestem Biosciences

How much has Bluestem Biosciences raised?
Bluestem Biosciences has raised $21.0M in total across 1 recorded funding rounds.
When was Bluestem Biosciences's last funding round?
Bluestem Biosciences's most recent recorded round was Early Stage VC in Jul 2022, raising $5.0M.